Literature DB >> 26419190

The importance of triaging in determining the quality of output from high-throughput screening.

Philip Jones1, Stuart McElroy1, Angus Morrison1, Andrew Pannifer1.   

Abstract

Keywords:  PAINS; academic drug discovery; high-throughput screening; triaging

Mesh：

Substances：

Year:  2015        PMID： 26419190     DOI： 10.4155/fmc.15.121

Source DB:  PubMed          Journal:  Future Med Chem        ISSN： 1756-8919            Impact factor:   3.808


× No keyword cloud information.
  4 in total

Review 1.  The European Lead Factory: A Blueprint for Public-Private Partnerships in Early Drug Discovery.

Authors:  Anna Karawajczyk; Kristina M Orrling; Jon S B de Vlieger; Ton Rijnders; Dimitrios Tzalis
Journal:  Front Med (Lausanne)       Date:  2017-01-19

2.  Using Microscale Thermophoresis to Characterize Hits from High-Throughput Screening: A European Lead Factory Perspective.

Authors:  Julie M Rainard; George C Pandarakalam; Stuart P McElroy
Journal:  SLAS Discov       Date:  2018-03       Impact factor: 3.341

3.  Identification of Compounds That Interfere with High-Throughput Screening Assay Technologies.

Authors:  Laurianne David; Jarrod Walsh; Noé Sturm; Isabella Feierberg; J Willem M Nissink; Hongming Chen; Jürgen Bajorath; Ola Engkvist
Journal:  ChemMedChem       Date:  2019-09-19       Impact factor: 3.466

4.  Hit Discovery for Public Target Programs in the European Lead Factory: Experiences and Output from Assay Development and Ultra-High-Throughput Screening.

Authors:  Saman Honarnejad; Stan van Boeckel; Helma van den Hurk; Steven van Helden
Journal:  SLAS Discov       Date:  2020-07-31       Impact factor: 3.341
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.